Chromosome 22q11.2 deletion syndrome: Difference between revisions
Jump to navigation
Jump to search
imported>Daniel Mietchen (slight addition) |
imported>Daniel Mietchen (+ref) |
||
| Line 1: | Line 1: | ||
{{subpages}} | {{subpages}} | ||
{{DirectRef}} | |||
'''Chromosome 22q11.2 deletion syndrome''' | '''Chromosome 22q11.2 deletion syndrome''' is a clinical condition due to [[microdeletion]]s in the [[chromosome band|11.2 region]] on [[human chromosome 22]]. The term is also often interchengeably used with [[velocardiofacial syndrome]] or [[DiGeorge syndrome]], although the overlap is not complete ([[CZ:Ref:Kobrynski 2007 Velocardiofacial syndrome, DiGeorge syndrome: the chromosome 22q11.2 deletion syndromes|Kobrynski and Sullivan, 2007]]). It was first diagnosed in 1968 by [[Angelo DiGeorge]] as an [[immunological]] syndrome but has since been found to be associated with a wide [[phenotype|phenotypic]] spectrum which also includes [[cardiovascular]], [[craniofacial]] and [[brain morphometric]] abnormalities as well as [[cognitive impairment]]s. It affects about one in 5000 newborn children and can be diagnosed with a [[genetic test]]. | ||
Revision as of 05:03, 25 November 2009
This article uses direct referencing.
Chromosome 22q11.2 deletion syndrome is a clinical condition due to microdeletions in the 11.2 region on human chromosome 22. The term is also often interchengeably used with velocardiofacial syndrome or DiGeorge syndrome, although the overlap is not complete (Kobrynski and Sullivan, 2007). It was first diagnosed in 1968 by Angelo DiGeorge as an immunological syndrome but has since been found to be associated with a wide phenotypic spectrum which also includes cardiovascular, craniofacial and brain morphometric abnormalities as well as cognitive impairments. It affects about one in 5000 newborn children and can be diagnosed with a genetic test.